“…Conversely, in the t(3;14) translocations, the IgH genes provide promoter and 5' untranslated sequences which substitute for the corresponding BCL6 sequences, a mechanism that we have called promoter substitution. While translocations involving promoter substitutions have not been observed before in B cell malignancies (for a review see Rabbitts, 1994), one example exists in T cell-derived acute lymphoblastic leukemia in which the chromosome lp33 deletion can join SIL exon 1 to TAL-] exon 3 in a head-to-tail fashion (Aplan et al, 1992;Baer, 1993) In all three cases studied here, IgH promoter regions (IS, or IY3) were found fused to BCL6 transcripts, while in two DLCL biopsies (KC1445 and SM1444; Figure 3), additional fusion transcripts initiated from further upstream D or V-D sequences could also be identified. Although the 5' termini and the abundance of the latter transcripts could not be characterized, the recurrent selection of I promoters, together with the fact that 13-BCL6 fusion transcripts represent the most abundant BCL6 RNA species in Ly8 cells ( Figure 4B), suggest that the recruitment of I promoters may be the most common and therefore the most biologically significant consequence of the Ig-BCL6 recombination.…”